Launches syringe and cartridge glass tubing in India
SCHOTT, a global pioneer in speciality glass, announced the addition of syringe and cartridge glass tubing to its existing state-of-the-art manufacturing capabilities in Jambusar, Gujarat.
The cutting-edge production is a direct technology transfer from SCHOTT’s renowned German expertise. It is set to meet the surging demand for biologics like semaglutide (belonging to the GLP-1 receptor agonist class) used for weight management and control of blood sugar levels in patients with type 2 diabetes.
“This strategic expansion marks a significant milestone in our journey to support pharmaceutical packaging capabilities in India,” said Sundeep Prabhu, Sr Vice President Sales and Marketing, SCHOTT Glass India. “As the first in India to locally manufacture high-precision syringe and cartridge glass tubing, we are not only elevating our operational capabilities but also reinforcing India’s healthcare self-sufficiency. This investment aligns strongly with the ‘Make in India’ initiative and showcases our ongoing commitment to driving excellence and economic growth in the country.”
“Our dedication goes beyond just production; it’s about empowering the entire pharmaceutical ecosystem in India. By bringing local production of our high-precision syringe and cartridge FIOLAX glass tubing to India, we’re ensuring a stable and consistent supply chain for critical drug delivery systems. With highly accurate inner diameter control and our perfeXion quality system analysing 100,000 data points every minute, we aim to achieve zero-defect manufacturing,” added Pawan Kumar Shukla, President and Managing Director, SCHOTT Glass India.
